Kamran Alam - Mar 11, 2025 Form 4 Insider Report for Taysha Gene Therapies, Inc. (TSHA)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Kamran Alam
Stock symbol
TSHA
Transactions as of
Mar 11, 2025
Transactions value $
-$50,435
Form type
4
Date filed
3/13/2025, 04:15 PM
Previous filing
Jan 3, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TSHA Common Stock Tax liability -$50.4K -29.8K -2.35% $1.69 1.24M Mar 11, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy the tax withholding obligations triggered by the vesting and settlement of restricted stock units and does not represent a discretionary transaction by the Reporting Person.